Published in J Antimicrob Chemother on March 01, 1978
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev (1996) 13.25
Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens. Antimicrob Agents Chemother (1982) 1.44
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol (1998) 1.30
Comparison of antibiotic susceptibility results obtained with Adatab and disc methods. J Clin Pathol (1984) 0.75
Beta-lactamase-producing, penicillin-resistant gonococcus. Lancet (1976) 10.90
Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother (1973) 8.83
Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet (1990) 6.99
In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrob Agents Chemother (1982) 6.97
Outbreak of hospital infection caused by contaminated autoclaved fluids. Lancet (1972) 6.85
Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence. Br J Vener Dis (1972) 5.87
Ultra-fast excited state dynamics in green fluorescent protein: multiple states and proton transfer. Proc Natl Acad Sci U S A (1996) 5.46
Hands as route of transmission for Klebsiella species. Br Med J (1977) 5.13
In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae. Lancet (1970) 5.05
In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases. Antimicrob Agents Chemother (1980) 4.43
Treatment of gonorrhoea with three different antibiotic regimes: doxycycline 300 mg., procaine penicillin plus benzyl penicillin 2.4 m.u., benzyl penicillin 5 m.u. plus probenecid. Br J Vener Dis (1970) 3.95
API ZYM: a simple rapid system for the detection of bacterial enzymes. J Clin Pathol (1977) 3.88
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases. Antimicrob Agents Chemother (1980) 3.68
Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Antimicrob Agents Chemother (1976) 3.55
Gonorrhoea in women. Diagnostic, clinical, and laboratory aspects. Lancet (1978) 3.51
Determination of antibiotic sensitivities by the Sensititre system. J Clin Pathol (1978) 2.79
Pseudomonas aeruginosa cross-infection due to contaminated respiratory apparatus. Lancet (1965) 2.78
Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings. Lancet (1983) 2.75
Diagnosis of gonorrhoea in women. Br J Vener Dis (1976) 2.67
Food as a source of Klebsiella species for colonisation and infection of intensive care patients. J Clin Pathol (1978) 2.65
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother (1995) 2.62
The comparative in-vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother (1986) 2.59
Pyogenic liver abscess caused by Streptococcus milleri. Lancet (1975) 2.37
Gardnerella vaginalis, anaerobes, and vaginal discharge. Lancet (1982) 2.34
Infective endocarditis, 1970-1979. A study of culture-positive cases in St. Thomas' Hospital. Q J Med (1980) 2.30
Gentamicin-resistant Klebsiella aerogenes in a urological ward. Lancet (1977) 2.30
Identification of Pseudomonas aeruginosa in the clinical laboratory. J Med Microbiol (1969) 2.20
Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother (1986) 2.16
The susceptibility of Neisseria gonorrhoeae to cefoxitin sodium. J Antimicrob Chemother (1978) 2.16
Antibiotic sensitivity of gonococci and treatment of gonorrhoea in Uganda. Br J Vener Dis (1970) 2.12
Epidemic methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1988) 2.09
Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother (1999) 2.08
Group B streptococci in the female genital tract. Br Med J (1976) 2.04
Assessment of a selective medium for the isolation of Neisseria gonorrhoeae. Br J Vener Dis (1979) 2.01
Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J (Clin Res Ed) (1985) 1.98
Microbiology of pyogenic liver abscess. Br Med J (Clin Res Ed) (1981) 1.97
An outbreak of extended-spectrum, beta-lactamase-producing Salmonella senftenberg in a burns ward. J Hosp Infect (1998) 1.97
The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae. J Antimicrob Chemother (1976) 1.96
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. J Antimicrob Chemother (1985) 1.96
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. J Antimicrob Chemother (2000) 1.95
The in-vitro activity of PD127,391, a new quinolone. J Antimicrob Chemother (1988) 1.95
Imported penicillinase producing Neisseria gonorrhoeae becomes endemic in London. Br J Vener Dis (1983) 1.91
Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase. J Clin Microbiol (1996) 1.89
Serological grouping of streptococci by a slide coagglutination method. J Clin Pathol (1977) 1.88
Reassessment of histone gene expression during cell cycle in human cells by using homologous H4 histone cDNA. Proc Natl Acad Sci U S A (1979) 1.87
Necrobacillosis: a forgotten disease. Br Med J (Clin Res Ed) (1984) 1.87
Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital. J Gen Microbiol (1980) 1.84
Comparison of radiometric and gas capture system for blood cultures. J Clin Pathol (1986) 1.81
An evaluation of near-patient testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther (1997) 1.80
Ceftazidime--a new extended-spectrum cephalosporin. Lancet (1982) 1.79
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79
Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit. Lancet (1971) 1.78
Ciprofloxacin for treating urethral gonorrhoea in men. Genitourin Med (1986) 1.78
Crystal structure and photodynamic behavior of the blue emission variant Y66H/Y145F of green fluorescent protein. Biochemistry (1997) 1.74
Disinfection of gastrointestinal fibre endoscopes. Lancet (1974) 1.71
A hospital outbreak of antibiotic-resistant Acinetobacter anitratus: epidemiology and control. J Hosp Infect (1980) 1.69
Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1989) 1.68
Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect (2004) 1.67
The application of flow cytometry to the study of bacterial responses to antibiotics. J Med Microbiol (1993) 1.66
Serum gentamicin assay: a comparison and assessment of different methods. J Clin Pathol (1974) 1.65
Bacteremia due to Escherichia coli: a study of 861 episodes. Rev Infect Dis (1991) 1.62
Metronidazole and anaerobic sepsis. Br Med J (1976) 1.62
Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis. Br Med J (1970) 1.59
Prophylactic peroperative intravenous metronidazole in elective colorectal surgery. Lancet (1979) 1.58
Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J Antimicrob Chemother (1990) 1.57
4-Quinolone-resistant Neisseria gonorrhoeae in the United Kingdom. J Med Microbiol (1991) 1.54
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. J Antimicrob Chemother (1981) 1.52
beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli. J Antimicrob Chemother (1992) 1.51
The magnitude and duration of ambulatory blood pressure reduction following acute exercise. J Hum Hypertens (1999) 1.50
Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomycin and clindamycin. J Med Microbiol (1976) 1.49
Anaerobic subareolar breast abscess. Lancet (1979) 1.49
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics. Antimicrob Agents Chemother (1994) 1.49
Antibacterial action of ciprofloxacin. Antimicrob Agents Chemother (1995) 1.48
Acute bacterial infection in kwashiorkor and marasmus. Br Med J (1968) 1.48
Epidemiological patterns of Klebsiella colonization and infection in an intensive care ward. J Hyg (Lond) (1978) 1.48
The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother (1990) 1.47
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. J Antimicrob Chemother (1984) 1.47
Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother (2001) 1.47
In-vitro antigonococcal activity of rosoxacin (WIN 35213). Br J Vener Dis (1981) 1.45
DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob Agents Chemother (1995) 1.45
Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis. Antimicrob Agents Chemother (1976) 1.45
Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother (1982) 1.45
Relative instability of cephaloridine to staphylococcal penicillinase. Nature (1965) 1.43
The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates. J Antimicrob Chemother (2001) 1.42
The beta-lactamases of Bacteroides species. J Antimicrob Chemother (1981) 1.41
Gonorrhoea. Lancet (1970) 1.40
Advances in antibiotics. Practitioner (1969) 1.39
MIC audit for routine ciprofloxacin sensitivity testing. J Antimicrob Chemother (1993) 1.39
Working with a new staff mix. RN (1995) 1.39
Effect of exercise on milk immunoglobulin A. Med Sci Sports Exerc (1997) 1.39
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother (1981) 1.38
The identification of pseudomonads and related bacteria in a clinical laboratory. J Med Microbiol (1978) 1.37
Diversity of staphylococci exhibiting high-level resistance to mupirocin. J Med Microbiol (1990) 1.35
Anaerobic curved rods in vaginitis. Lancet (1982) 1.35
Mechanisms of resistance to aminoglycosides in clinical isolates. J Antimicrob Chemother (1982) 1.30
Susceptibility of Bacteroides fragilis to trimethoprim and sulphamethoxazole. Lancet (1974) 1.30
Brucella melitensis endocarditis: successful treatment of an infected prosthetic mitral valve. Thorax (1974) 1.29
Clinical uses and control of rifampicin and clindamycin. J Clin Pathol (1971) 1.29
Strategies for typing and properties of epidemic methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol (1986) 1.26